{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:17:05Z","timestamp":1761862625708,"version":"build-2065373602"},"reference-count":155,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Rheumatic Disease Clinics of North America"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1016\/j.rdc.2006.03.003","type":"journal-article","created":{"date-parts":[[2007,1,10]],"date-time":"2007-01-10T10:09:23Z","timestamp":1168423763000},"page":"333-357","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Treatment of Crystal Arthropathy\u2014History and Advances"],"prefix":"10.1016","volume":"32","author":[{"given":"George","family":"Nuki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"1964","series-title":"A short history of the gout and the rheumatic diseases","author":"Copeman","key":"10.1016\/j.rdc.2006.03.003_bib1"},{"key":"10.1016\/j.rdc.2006.03.003_bib2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/art.1780040104","article-title":"A gallery of gout. Being a miscellany of prints and caricatures from the 16th century to the present day","volume":"4","author":"Rodnan","year":"1961","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2006.03.003_bib3","series-title":"Gout and hyperuricaemia","first-page":"2","article-title":"An abbreviated history of gout","author":"Wyngaarden","year":"1976"},{"key":"10.1016\/j.rdc.2006.03.003_bib4","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/art.1780130408","article-title":"A historical note: Leeuwenhoek's description of crystals from a gouty tophus","volume":"13","author":"McCarty","year":"1970","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2006.03.003_bib5","first-page":"386","article-title":"On gouty and urinary concretions","volume":"87","author":"Wollaston","year":"1797","journal-title":"Philos Trans R Soc Lond"},{"key":"10.1016\/j.rdc.2006.03.003_bib6","first-page":"73","article-title":"Examen chemicum calculi urinarii","volume":"2","author":"Scheele","year":"1776","journal-title":"Opuscula"},{"key":"10.1016\/j.rdc.2006.03.003_bib7","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1177\/095952874803100109","article-title":"Observations on certain pathological conditions of the blood and urine in gout, rheumatism and Bright's disease","volume":"31","author":"Garrod","year":"1848","journal-title":"Trans Med Chir Soc Edinburgh"},{"key":"10.1016\/j.rdc.2006.03.003_bib8","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/095952875403700107","article-title":"On the blood and effused fluids in gout, rheumatism and Bright's disease","volume":"37","author":"Garrod","year":"1854","journal-title":"Trans Med Chir Soc Edinburgh"},{"year":"1859","series-title":"The nature and treatment of gout and rheumatic gout","author":"Garrod","key":"10.1016\/j.rdc.2006.03.003_bib9"},{"key":"10.1016\/j.rdc.2006.03.003_bib10","series-title":"The nature and treatment of gout and rheumatic gout","first-page":"251","author":"Garrod","year":"1863"},{"year":"1876","series-title":"The nature and treatment of gout and rheumatic gout","author":"Garrod","key":"10.1016\/j.rdc.2006.03.003_bib11"},{"key":"10.1016\/j.rdc.2006.03.003_bib12","first-page":"266","article-title":"Experimentelle Untersuchungen uber das Wesen der Gichtknoten","volume":"63","author":"Freudweiler","year":"1899","journal-title":"Dtsch Arch Klin Med"},{"key":"10.1016\/j.rdc.2006.03.003_bib13","first-page":"81","article-title":"Schicksal und Wirkungen des sauren harnsauren Natrons in Bauch und Gelenkhohledes Kanninschens","volume":"67","author":"His","year":"1900","journal-title":"Dtsch Arch Klin Med"},{"key":"10.1016\/j.rdc.2006.03.003_bib14","first-page":"295","article-title":"Acute synovitis in normal joints of man and dog produced by injections of microcrystalline sodium urate, calcium oxalate and corticosteroid esters","volume":"5","author":"Faires","year":"1962","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2006.03.003_bib15","first-page":"469","article-title":"Inflammatory reactions to sodium urate. Its possible relationship to genesis of acute gouty arthritis","volume":"180","author":"Seegmiller","year":"1962","journal-title":"JAMA"},{"key":"10.1016\/j.rdc.2006.03.003_bib16","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/art.1780050610","article-title":"The old and the new concepts of acute gouty arthritis","volume":"5","author":"Seegmiller","year":"1962","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2006.03.003_bib17","doi-asserted-by":"crossref","first-page":"452","DOI":"10.7326\/0003-4819-54-3-452","article-title":"Identification of urate crystals in gouty synovial fluid","volume":"54","author":"McCarty","year":"1961","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rdc.2006.03.003_bib18","doi-asserted-by":"crossref","first-page":"711","DOI":"10.7326\/0003-4819-56-5-711","article-title":"The significance of calcium phosphate crystals in the synovial fluid of arthritis patients: the \u2018pseudogout syndrome\u2019. I. Clinical aspects","volume":"56","author":"McCarty","year":"1962","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rdc.2006.03.003_bib19","doi-asserted-by":"crossref","first-page":"738","DOI":"10.7326\/0003-4819-56-5-738","article-title":"The significance of calcium phosphate crystals in the synovial fluid of arthritic patients. II. Identification of crystals","volume":"56","author":"Kohn","year":"1962","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rdc.2006.03.003_bib20","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1084\/jem.124.1.99","article-title":"Crystal-induced inflammation in canine joints. I. An experimental model with quantification of the host response","volume":"124","author":"McCarty","year":"1966","journal-title":"J Exp Med"},{"key":"10.1016\/j.rdc.2006.03.003_bib21","first-page":"287","article-title":"Pseudogout syndrome. IV. Early (perilacunar) and \u2018mature\u2019 cartilaginous deposits of monoclinic and triclinic crystals of calcium pyrophosphate dehydrate; Koch's postulates and possible pathogenesis","volume":"6","author":"McCarty","year":"1963","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2006.03.003_bib22","series-title":"Arthritis and allied diseases","first-page":"1276","article-title":"Calcium pyrophosphate deposition disease: pseudogout: articular chondrocalcinosis","author":"McCarty","year":"1979"},{"key":"10.1016\/j.rdc.2006.03.003_bib23","first-page":"149","article-title":"Zur Pathologie und Therapie der Zwischenknorpelekrankungen des Kniegelenkes","volume":"146","author":"Mandl","year":"1927","journal-title":"Arch Klin Chir"},{"key":"10.1016\/j.rdc.2006.03.003_bib24","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/art.1780180109","article-title":"Chondrocalcinosis in elderly persons","volume":"18","author":"Ellman","year":"1975","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2006.03.003_bib25","first-page":"1241","article-title":"The prevalence of chondrocalcinosis in the elderly and its association with knee osteoarthritis: the Framingham Study","volume":"16","author":"Felson","year":"1989","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rdc.2006.03.003_bib26","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1136\/ard.29.4.380","article-title":"Periarticular calcific deposits mimicking acute arthritis","volume":"29","author":"Swannell","year":"1970","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2006.03.003_bib27","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1056\/NEJM190703211561201","article-title":"Subdeltoid bursitis","volume":"56","author":"Painter","year":"1907","journal-title":"Boston Med Surg J"},{"key":"10.1016\/j.rdc.2006.03.003_bib28","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1093\/rheumatology\/23.2.84","article-title":"Apatite associated destructive arthropathy","volume":"23","author":"Dieppe","year":"1984","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.rdc.2006.03.003_bib29","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/art.1780240303","article-title":"\u201cMilwaukee shoulder\u201d: association of microspheroids containing hydroxyapatite crystals, active collagenase and neutral protease with rotator cuff defects","volume":"24","author":"McCarty","year":"1981","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2006.03.003_bib30","first-page":"107","article-title":"L'epaule senile haemorrhagique","volume":"1","author":"de Seze","year":"1968","journal-title":"L'Actualite Rheumatol"},{"key":"10.1016\/j.rdc.2006.03.003_bib31","first-page":"861","article-title":"Hydroxyapatite crystals are a frequent finding in osteoarthritic synovial fluid, but are not related to increased concentration of keratin sulphate or interleukin-1 beta","volume":"18","author":"Carroll","year":"1991","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rdc.2006.03.003_bib32","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0090-4295(84)90058-X","article-title":"Shusruta of India: pioneer of vesico lithotomy","volume":"23","author":"Das","year":"1984","journal-title":"Urology"},{"key":"10.1016\/j.rdc.2006.03.003_bib33","series-title":"The genuine works of Hippocrates. Translated from the Greek with a preliminary discourse and annotations","first-page":"780","author":"Adams","year":"1849"},{"year":"1849","series-title":"The genuine works, vols. 1\u20132","author":"Hippocrates","key":"10.1016\/j.rdc.2006.03.003_bib34"},{"key":"10.1016\/j.rdc.2006.03.003_bib35","unstructured":"Celsus. On medicine. London; 1755 [Grieve J, Trans.]"},{"year":"1958","series-title":"Avicenna: his life and works","author":"Afnan","key":"10.1016\/j.rdc.2006.03.003_bib36"},{"year":"1856","key":"10.1016\/j.rdc.2006.03.003_bib37","article-title":"The extant works"},{"key":"10.1016\/j.rdc.2006.03.003_bib38","unstructured":"Temple W. An essay on the cure of the gout. London: Edward Gellibrand; 1681"},{"year":"1683","series-title":"Tractatus de podagra et hydrope","author":"Sydenham","key":"10.1016\/j.rdc.2006.03.003_bib39"},{"year":"1802","series-title":"Commentaries on the history and cure of diseases","author":"Heberden","key":"10.1016\/j.rdc.2006.03.003_bib40"},{"key":"10.1016\/j.rdc.2006.03.003_bib41","first-page":"331","article-title":"Local ice therapy during bouts of acute gouty arthritis","volume":"29","author":"Schlesinger","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rdc.2006.03.003_bib42","first-page":"2285","article-title":"Treatment of acute attacks of gout with a small dose of itraarticular triamcinolone acetonide","volume":"26","author":"Fernandez","year":"1999","journal-title":"J Rheumatol"},{"year":"1930","series-title":"The papyrus Ebers","author":"Bryan","key":"10.1016\/j.rdc.2006.03.003_bib43"},{"key":"10.1016\/j.rdc.2006.03.003_bib44","series-title":"A short history of the gout and other rheumatic diseases","first-page":"38","article-title":"The story of colchicum","author":"Copeman","year":"1964"},{"year":"1764","series-title":"An essay on the use and effects of the root of the Colchicum autumnale or meadow saffron","author":"Von Stoerk","key":"10.1016\/j.rdc.2006.03.003_bib45"},{"key":"10.1016\/j.rdc.2006.03.003_bib46","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/0049-0172(82)90065-8","article-title":"The efficacy of colchicine prophylaxis in articular gout. A reappraisal after 20 years","volume":"12","author":"Yu","year":"1982","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.rdc.2006.03.003_bib47","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1056\/NEJM198706183162502","article-title":"Colchicine myopathy and neuropathy","volume":"316","author":"Kunci","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rdc.2006.03.003_bib48","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0736-4679(02)00430-4","article-title":"Deaths associated with inappropriate intravenous colchicine administration","volume":"22","author":"Bonnel","year":"2002","journal-title":"J Emerg Med"},{"key":"10.1016\/j.rdc.2006.03.003_bib49","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1445-5994.1987.tb01232.x","article-title":"Does colchicine work? The results of the first controlled study in acute gout","volume":"17","author":"Ahern","year":"1987","journal-title":"Aust N Z J Med"},{"key":"10.1016\/j.rdc.2006.03.003_bib50","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1136\/bmj.327.7426.1275","article-title":"Cochicine in acute gout","volume":"327","author":"Morris","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.rdc.2006.03.003_bib51","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/art.1780170517","article-title":"Prophylactic colchicine therapy in intercritical gout. A placebo-controlled study of probenecid\u2013treated patients","volume":"17","author":"Paulus","year":"1974","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2006.03.003_bib52","first-page":"2429","article-title":"Colchicine for prophylaxis of acute flares when initiating allopurinol for chronic gouty arthritis","volume":"31","author":"Borstad","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rdc.2006.03.003_bib53","first-page":"804","article-title":"Colchine prophylaxis in pseudogout","volume":"13","author":"Alvarellos","year":"1986","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rdc.2006.03.003_bib54","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0889-857X(21)00376-8","article-title":"Treatment of refractory crystal-associated arthritis","volume":"21","author":"Rosenthal","year":"1995","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.rdc.2006.03.003_bib55","unstructured":"Jordan K.L., Cameron S., Snaith M., et al. British Society for Rheumatology and British Health Professionals in Rheumatology Guidelines for the Management of Gout. Rheumatology, in press"},{"key":"10.1016\/j.rdc.2006.03.003_bib56","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00002281-199206000-00002","article-title":"Treatment of gout and crystal arthropathies and uses and mechanisms of action of nonsteroidal anti-inflammatory drugs","volume":"4","author":"Abramson","year":"1992","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.rdc.2006.03.003_bib57","unstructured":"Zhang W., Doherty M., Bardin T., et al. EULAR evidence-based recommendations for gout: part II. Management. Ann Rheum Dis, in press"},{"key":"10.1016\/j.rdc.2006.03.003_bib58","doi-asserted-by":"crossref","first-page":"306","DOI":"10.3109\/rhe1.1963.9.issue-1-4.35","article-title":"A method for measuring swelling of hands and feet. II. Influence of new anti-inflammatory drug, indomethacinin acute gout","volume":"9","author":"Smyth","year":"1963","journal-title":"Acta Rheumatol Scand"},{"key":"10.1016\/j.rdc.2006.03.003_bib59","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1136\/bmj.2.5363.965","article-title":"Indomethacin: a new non-steroid anti-inflammatory agent","volume":"2","author":"Hart","year":"1963","journal-title":"BMJ"},{"key":"10.1016\/j.rdc.2006.03.003_bib60","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1136\/bmj.2.5547.272","article-title":"Regimen of indomethacin therapy in acute gouty arthritis","volume":"2","author":"Emmerson","year":"1967","journal-title":"BMJ"},{"key":"10.1016\/j.rdc.2006.03.003_bib61","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1136\/ard.26.2.127","article-title":"Side effects of indomethacin","volume":"26","author":"Boardman","year":"1967","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2006.03.003_bib62","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/art.1780150316","article-title":"The treatment of gout","volume":"15","author":"Wallace","year":"1972","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2006.03.003_bib63","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1056\/NEJM199602153340707","article-title":"The management of gout","volume":"334","author":"Emmerson","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rdc.2006.03.003_bib64","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1056\/NEJMcp030733","article-title":"Gout (clinical practice)","volume":"349","author":"Terkeltaub","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rdc.2006.03.003_bib65","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1136\/bmj.324.7352.1488","article-title":"Randomised double-blind trial of etoricoxib and indometacin in treatment of acute gouty arthritis","volume":"324","author":"Schumacher","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.rdc.2006.03.003_bib66","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1056\/NEJMoa050405","article-title":"Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma protection","volume":"352","author":"Solomon","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rdc.2006.03.003_bib67","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1056\/NEJMoa050493","article-title":"Cardivascular events associated with rofecoxib in a colorectal adenoma prevention trial","volume":"352","author":"Bresalier","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rdc.2006.03.003_bib68","first-page":"1684","article-title":"Systematic review and meta-analysis of the risk of major cardiovascular events with etoricoxib therapy","volume":"118","author":"Aldington","year":"2005","journal-title":"N Z Med J"},{"key":"10.1016\/j.rdc.2006.03.003_bib69","unstructured":"Cox J.R. Galen. The writings of Galen and Hippocrates epitomised. Philadephia; 1846"},{"key":"10.1016\/j.rdc.2006.03.003_bib70","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1056\/NEJMoa035700","article-title":"Purine-rich foods, dairy and protein intake, and the risk of gout in men","volume":"359","author":"Choi","year":"2004","journal-title":"N Engl J Med"},{"year":"1634","series-title":"The works of that famous chirurgeon Ambrose Parey","author":"Johnson","key":"10.1016\/j.rdc.2006.03.003_bib71"},{"key":"10.1016\/j.rdc.2006.03.003_bib72","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/jn\/101.3.347","article-title":"Hereditary susceptibility of dietary induction of gout in selected lines of chickens","volume":"101","author":"Peterson","year":"1971","journal-title":"J Nutr"},{"key":"10.1016\/j.rdc.2006.03.003_bib73","doi-asserted-by":"crossref","first-page":"931","DOI":"10.3181\/00379727-146-38222","article-title":"Specificity of the renal transport impairment in chickens having hyperuricaemia and articular gout","volume":"146","author":"Austic","year":"1974","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.rdc.2006.03.003_bib74","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1136\/ard.21.4.325","article-title":"Gout in the time and person of George IV","volume":"21","author":"Bywaters","year":"1962","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2006.03.003_bib75","first-page":"401","article-title":"Two epidemics of gout","volume":"45","author":"Ball","year":"1971","journal-title":"Bull Hist Med"},{"key":"10.1016\/j.rdc.2006.03.003_bib76","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1172\/JCI111512","article-title":"Ethanol-induced activation of adenine nucleotide turnover. Evidence for a role of acetate","volume":"74","author":"Puig","year":"1984","journal-title":"J Clin Invest"},{"key":"10.1016\/j.rdc.2006.03.003_bib77","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1056\/NEJM198212233072602","article-title":"Ethanol-induced hyperuricaemia: evidence for increased urate production by activation of adenine nucleotide turnover","volume":"307","author":"Faller","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rdc.2006.03.003_bib78","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1172\/JCI104643","article-title":"Interelation of uric acid and ethanol metabolism in man","volume":"41","author":"Lieber","year":"1962","journal-title":"J Clin Invest"},{"key":"10.1016\/j.rdc.2006.03.003_bib79","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/rheumatology\/23.3.203","article-title":"Beer drinking and its effect on uric acid","volume":"23","author":"Gibson","year":"1984","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.rdc.2006.03.003_bib80","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/S0140-6736(04)16000-5","article-title":"Alcohol intake and the risk of incident gout in men","volume":"363","author":"Choi","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.rdc.2006.03.003_bib81","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0021-9258(18)86414-6","article-title":"1. The influence of high protein diets on the endogenous uric acid elimination","volume":"36","author":"Lewis","year":"1918","journal-title":"J Biol Chem"},{"key":"10.1016\/j.rdc.2006.03.003_bib82","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1056\/NEJMoa035700","article-title":"Purine-rich foods, dairy and protein intake, and the risk of gout in men","volume":"350","author":"Choi","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rdc.2006.03.003_bib83","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/ajcn\/53.3.665","article-title":"Milk- and soy-protein ingestion: acute effect on serum uric acid concentration","volume":"53","author":"Garrel","year":"1991","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.rdc.2006.03.003_bib84","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/BF01719431","article-title":"The influence of dairy products on plasma uric acid in women","volume":"11","author":"Ghadirian","year":"1995","journal-title":"Eur J Epidemiol"},{"year":"1840","series-title":"The works of the Rev. Sydney Smith, vols. 1\u20133","author":"Smith","key":"10.1016\/j.rdc.2006.03.003_bib85"},{"key":"10.1016\/j.rdc.2006.03.003_bib86","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/S0140-6736(72)92271-4","article-title":"Effect of weight loss on plasma and urinary levels of uric acid","volume":"2","author":"Nicholls","year":"1972","journal-title":"Lancet"},{"key":"10.1016\/j.rdc.2006.03.003_bib87","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1136\/ard.59.7.539","article-title":"Beneficial effects of weight loss associated with moderate calorie\/carbohydrate restriction, and increased proportional intake of protein and unsaturated fat on serum urate and lipoprotein levels in gout: a pilot study","volume":"59","author":"Dessein","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2006.03.003_bib88","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/BF01966284","article-title":"Physiologish-chemische Untersuchungen uber die Lachsmilch","volume":"37","author":"Miescher","year":"1896","journal-title":"Arch Exp Pathol Pharmakol"},{"year":"1907","series-title":"Untersuchungen in der Puringruppe","author":"Fischer","key":"10.1016\/j.rdc.2006.03.003_bib89"},{"key":"10.1016\/j.rdc.2006.03.003_bib90","series-title":"Uric acid as a factor in the causation of disease","first-page":"797","author":"Haig","year":"1908"},{"key":"10.1016\/j.rdc.2006.03.003_bib91","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/978-1-4757-1433-3_9","article-title":"Effect of ribomononucleotides given orally on uric acid production in man","volume":"41","author":"Griebsch","year":"1974","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.rdc.2006.03.003_bib92","first-page":"331","article-title":"The action of cholin carbonic acid and its derivatives","volume":"43","author":"Nicolaaier","year":"1908","journal-title":"Dtsch Arch Klin Med"},{"key":"10.1016\/j.rdc.2006.03.003_bib93","first-page":"104","article-title":"Toxic hepatitis from cinchophen: report of 3 cases (In Spanish)","volume":"97","author":"Cutrin Prieto","year":"1991","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.rdc.2006.03.003_bib94","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1001\/jama.1936.02770360006003","article-title":"Cinchophen. Is there a safe method of administration?","volume":"107","author":"Palmer","year":"1936","journal-title":"JAMA"},{"key":"10.1016\/j.rdc.2006.03.003_bib95","first-page":"331","article-title":"Studies in gout, with particular reference to the value of sodium salicylate in treatment","volume":"22","author":"Marson","year":"1953","journal-title":"Q J Med"},{"key":"10.1016\/j.rdc.2006.03.003_bib96","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1172\/JCI103905","article-title":"Study of the paradoxical effects of salicylate in low, intermediate and high dosage on the renal mechanisms for excretion of urate in man","volume":"38","author":"Yu","year":"1959","journal-title":"J Clin Invest"},{"key":"10.1016\/j.rdc.2006.03.003_bib97","first-page":"372","article-title":"The clinical and metabolic effects of Benemid in patients with gout","volume":"64","author":"Talbott","year":"1951","journal-title":"Trans Assoc Am Physicians"},{"key":"10.1016\/j.rdc.2006.03.003_bib98","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S0022-3565(25)11890-9","article-title":"A potent new uricosuric agent, the sulfoxide metabolite of the phenylbutazone analogue G-26571","volume":"119","author":"Burns","year":"1957","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.rdc.2006.03.003_bib99","first-page":"1193","article-title":"Action uricosurique de certains derives du benzofuranne","volume":"116","author":"Delbarre","year":"1965","journal-title":"Soc Med Hop Paris"},{"year":"1967","series-title":"Gout","author":"Talbott","key":"10.1016\/j.rdc.2006.03.003_bib100"},{"key":"10.1016\/j.rdc.2006.03.003_bib101","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/0002-9343(51)90028-9","article-title":"Mobilization of gouty tophi by protracted use of uricosuric agents","volume":"11","author":"Yu","year":"1951","journal-title":"Am J Med"},{"key":"10.1016\/j.rdc.2006.03.003_bib102","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/0002-9343(74)90634-2","article-title":"Milestones in the treatment of gout","volume":"56","author":"Yu","year":"1974","journal-title":"Am J Med"},{"key":"10.1016\/j.rdc.2006.03.003_bib103","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/S0140-6736(57)91541-6","article-title":"Protracted uricosuric therapy in tophaceous gout","volume":"2","author":"Gutman","year":"1957","journal-title":"Lancet"},{"key":"10.1016\/j.rdc.2006.03.003_bib104","first-page":"31","article-title":"Effect of Anturane on serum uric acid and cholesterol in gout. A long-term study","volume":"8","author":"Kuzell","year":"1964","journal-title":"Acta Rheumatol Scand Suppl"},{"key":"10.1016\/j.rdc.2006.03.003_bib105","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00124743-199904000-00003","article-title":"Treatment of chronic gout in patients with renal function impairment: an open, randomized, actively controlled study","volume":"5","author":"Perez-Ruiz","year":"1999","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.rdc.2006.03.003_bib106","first-page":"651","article-title":"Benzbromarone withdrawn from the European market: another case of \u2018absence of evidence is evidence of absence\u2019?","volume":"22","author":"Jansen","year":"2004","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.rdc.2006.03.003_bib107","first-page":"149","article-title":"Preliminary studies with azapropazone in gout and hyperuricaemia","volume":"6","author":"Thomas","year":"1983","journal-title":"Eur J Rheumatol Inflamm"},{"key":"10.1016\/j.rdc.2006.03.003_bib108","first-page":"392","article-title":"The treatment of gout with azapropazone: clinical and experimental studies","volume":"4","author":"Dieppe","year":"1981","journal-title":"Eur J Rheumatol Inflamm"},{"key":"10.1016\/j.rdc.2006.03.003_bib109","first-page":"409","article-title":"Comparative trial of azapropazone and indomethacin plus allopurinol in acute gout and hyperuricaemia","volume":"37","author":"Fraser","year":"1987","journal-title":"J R Coll Gen Pract"},{"key":"10.1016\/j.rdc.2006.03.003_bib110","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0140-6736(94)91843-0","article-title":"Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs","volume":"343","author":"Garcia Rodriguez","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.rdc.2006.03.003_bib111","unstructured":"Karolinska Institute. Nobel Assembly press release. October 17, 1988"},{"key":"10.1016\/j.rdc.2006.03.003_bib112","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0006-2952(63)90012-1","article-title":"Potentiation by inhibition of drug degradation: S-substituted purines and xanthine oxidase","volume":"12","author":"Elion","year":"1963","journal-title":"Bichem Pharmacol"},{"key":"10.1016\/j.rdc.2006.03.003_bib113","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/S0021-9258(18)70884-3","article-title":"Pyrazolopyrimidines as inhibitors and substrates of xanthine oxidase","volume":"226","author":"Feigelson","year":"1957","journal-title":"J Biol Chem"},{"key":"10.1016\/j.rdc.2006.03.003_bib114","first-page":"126","article-title":"Effects of a xanthine oxidase inhibitor on thiopurine metabolism, hyperuricaemia and gout","volume":"76","author":"Rundles","year":"1963","journal-title":"Trans Assoc Am Physicians"},{"key":"10.1016\/j.rdc.2006.03.003_bib115","doi-asserted-by":"crossref","first-page":"842","DOI":"10.7326\/0003-4819-62-4-842","article-title":"Allopurinol in the treatment of gout","volume":"62","author":"Wyngaarden","year":"1965","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rdc.2006.03.003_bib116","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1002\/art.1780341203","article-title":"Influence of antihyperuricaemic therapy on the clinical and radiographic progression of Gout","volume":"34","author":"McCarthy","year":"1991","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2006.03.003_bib117","first-page":"355","article-title":"Effect of a urate lowering therapy on the velocity of size reduction of tophi in chronic gout","volume":"47","author":"Perez-Ruiz","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2006.03.003_bib118","first-page":"165","article-title":"(Clinical and socio-medical aspects of long-term uricostatic treatment of primary gout (a 5\u201310 year study) (German)","volume":"37","author":"Klein","year":"1978","journal-title":"Z Rheumatol"},{"key":"10.1016\/j.rdc.2006.03.003_bib119","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1056\/NEJM196802082780601","article-title":"An enzymatic basis for variation in response to allopurinol","volume":"278","author":"Kelley","year":"1968","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rdc.2006.03.003_bib120","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1365-2125.1988.tb03401.x","article-title":"Allopurinol dosage selection: relationships between dose and plasma oxypurinol and urate concentrations and urinary urate excretion","volume":"26","author":"Day","year":"1988","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.rdc.2006.03.003_bib121","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1136\/ard.57.9.545","article-title":"Efficacy of allopurinol and benzbromarone for the control of hyperuricaemia. A pathogenic approach to the treatment of primary chronic gout","volume":"57","author":"Perez-Ruiz","year":"1998","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2006.03.003_bib122","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1056\/NEJMoa050373","article-title":"Febuxostat compared with allopurinol in patients with hyperuricaemia and gout","volume":"353","author":"Becker","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rdc.2006.03.003_bib123","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1136\/ard.60.10.981","article-title":"Relation between adverse events associated with allopurinol and renal function in patients with gout","volume":"60","author":"Vazquez-Mellado","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2006.03.003_bib124","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/rheumatology\/26.6.445","article-title":"Plasma oxypurinol concentrations during allopurinol therapy","volume":"26","author":"Emmerson","year":"1987","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.rdc.2006.03.003_bib125","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1002\/art.20935","article-title":"Febuxostat, a novel non- purine selective inhibitor of xanthine oxidase: a 28-day, multicenter, phase II, randomized, double-blind, placebo-controlled dose-response clinical trial examining safety and efficacy in patients with gout","volume":"52","author":"Becker","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"Suppl","key":"10.1016\/j.rdc.2006.03.003_bib126","first-page":"S108","article-title":"Reduction in topus size in subjects with chronic gout treated with febuxostat or allopurinol for 52weeks\u2014FACT trial [abstract]","volume":"52","author":"Wortmann","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2006.03.003_bib127","doi-asserted-by":"crossref","first-page":"229","DOI":"10.7326\/0003-4819-64-2-229","article-title":"Allopurinol in the treatment of gout","volume":"64","author":"Rundles","year":"1966","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rdc.2006.03.003_bib128","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/art.1780090306","article-title":"Effects of allopurinol, a xanthine oxidase inhibitor, and sulphinpyrazone upon the urinary and serum urate concentrations in eight patients with tophaceous gout","volume":"9","author":"Goldfarb","year":"1966","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2006.03.003_bib129","first-page":"460","article-title":"[Long-lasting normalization of uric acid after combination therapy with 300mg allopurinol and 60mg benzbromarone in patients with gout and hyperuricaemia]","volume":"87","author":"Matkies","year":"1992","journal-title":"Med Klin"},{"key":"10.1016\/j.rdc.2006.03.003_bib130","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1136\/annrheumd00512-0010","article-title":"Enzymatic and metabolic studies with allopurinol","volume":"25","author":"Elion","year":"1966","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2006.03.003_bib131","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0002-9343(68)90008-9","article-title":"Renal clearance of oxypurinol, the chief metabolite of allopurinol","volume":"45","author":"Elion","year":"1968","journal-title":"Am J Med"},{"key":"10.1016\/j.rdc.2006.03.003_bib132","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/BF00315283","article-title":"The effect of benzbromarone on allopurinol\/ oxypurinol kinetics in patients with gout","volume":"44","author":"Muller","year":"1993","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.rdc.2006.03.003_bib133","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1126\/science.125.3254.937","article-title":"Uricolytic activity of purified uricase in two human beings","volume":"125","author":"London","year":"1957","journal-title":"Science"},{"key":"10.1016\/j.rdc.2006.03.003_bib134","first-page":"1109","article-title":"Uricolytic therapy. Value of urate oxidase in the treatment of hyperuricaemias","volume":"4","author":"Potaux","year":"1975","journal-title":"Nouv Press Med"},{"issue":"32","key":"10.1016\/j.rdc.2006.03.003_bib135","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.2174\/138161205774913291","article-title":"Rasburicase: a new approach for preventing and \/or treating tumor lysis syndrome","volume":"11","author":"Bessmertney","year":"2005","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.rdc.2006.03.003_bib136","first-page":"392","article-title":"Urate oxidase for the treatment of tophaceous gout in heart transplant recipients. A report of three cases","volume":"62","author":"Rozenberg","year":"1995","journal-title":"Rev Rhum Engl Ed"},{"key":"10.1016\/j.rdc.2006.03.003_bib137","article-title":"Rasburicase treatment in severe tophaceous gout: a novel therapeutic option","author":"Moolenburgh","year":"2005","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.rdc.2006.03.003_bib138","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1093\/ndt\/gfh629","article-title":"Urate oxidase (rasburicase) for treatment of severe tophaceous gout","volume":"20","author":"Vogt","year":"2005","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1016\/j.rdc.2006.03.003_bib139","doi-asserted-by":"crossref","first-page":"R12","DOI":"10.1186\/ar1861","article-title":"Control of hyperuricaemia in subjects with refractory gout, and induction of antibody against poly(ethylene) glycol (PEG), in a phase I trial of subcutaneous PEGylated urate oxidase","volume":"8","author":"Ganson","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.rdc.2006.03.003_bib140","first-page":"S679","article-title":"A phase-2 study of multiple doses of intravenous polyethylene glycol (PEG)\u2013uricase in patients with hyperuricaemia and refractory gout [abstract]","volume":"52","author":"Sundy","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2006.03.003_bib141","first-page":"S105","article-title":"Resolution of tophi with intravenous PEG-Uricase in refractory gout [abstract]","volume":"52","author":"Baraf","year":"2005","journal-title":"Arthritis Rheum"},{"year":"1997","series-title":"Bisphosphonates in bone disease. From the laboratory to the patient","author":"Fleisch","key":"10.1016\/j.rdc.2006.03.003_bib142"},{"key":"10.1016\/j.rdc.2006.03.003_bib143","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0006-291X(76)90714-2","article-title":"The presence of \u03b3-carboxyglutamic acid in the proteins associated with ectopic calcification","volume":"73","author":"Lian","year":"1976","journal-title":"Biochim Biophys Res Com"},{"key":"10.1016\/j.rdc.2006.03.003_bib144","first-page":"896","article-title":"Probenecid inhibits transforming growth factor \u03b21 induced pyrophosphate elaboration by chondrocytes","volume":"21","author":"Rosenthal","year":"1993","journal-title":"J Rheumatol"},{"issue":"Suppl","key":"10.1016\/j.rdc.2006.03.003_bib145","first-page":"S160","article-title":"Probenecid therapy of refractory CPPD deposition disease","volume":"42","author":"Trostle","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2006.03.003_bib146","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s11926-001-0047-9","article-title":"Phosphocitrate as a potential therapeutic strategy for crystal deposition disease","volume":"3","author":"Cheung","year":"2001","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.rdc.2006.03.003_bib147","doi-asserted-by":"crossref","first-page":"530","DOI":"10.2741\/1549","article-title":"Basic calcium phosphate crystals as a unique therapeutic target in osteoarthritis","volume":"10","author":"Whelan","year":"2005","journal-title":"Front Biosci"},{"key":"10.1016\/j.rdc.2006.03.003_bib148","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1002\/art.1780361116","article-title":"Phosphocitrate prevents disease progression in murine progressive ankylosis","volume":"36","author":"Krug","year":"1993","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2006.03.003_bib149","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1126\/science.155.3770.1682","article-title":"An enzyme defect associated with a sex-linked human neurological disorder and excessive purine synthesis","volume":"155","author":"Seegmiller","year":"1967","journal-title":"Science"},{"key":"10.1016\/j.rdc.2006.03.003_bib150","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJM197011262832211","article-title":"The purine revolution","volume":"283","author":"Lesch","year":"1970","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rdc.2006.03.003_bib151","doi-asserted-by":"crossref","first-page":"C1","DOI":"10.1152\/ajpcell.2001.281.1.C1","article-title":"Inorganic phosphate generation and disposition in pathophysiology","volume":"281","author":"Terkeltaub","year":"2001","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.rdc.2006.03.003_bib152","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/956","article-title":"Mutation in Npps in a mouse model of ossification of the posterior longitudinal ligament of the spine","volume":"19","author":"Okawa","year":"1998","journal-title":"Nat Genet"},{"key":"10.1016\/j.rdc.2006.03.003_bib153","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/oxfordjournals.jhered.a109459","article-title":"Progressive ankylosis, a new skeletal mutation in the mouse","volume":"72","author":"Sweet","year":"1981","journal-title":"J Hered"},{"key":"10.1016\/j.rdc.2006.03.003_bib154","first-page":"417","article-title":"Les chondrocacinoses articulaires familiales: etude d'une famille alsacienne","volume":"185","author":"Netter","year":"2001","journal-title":"Bull Acad Nat Med"},{"key":"10.1016\/j.rdc.2006.03.003_bib155","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1002\/art.20978","article-title":"Association of sporadic chondrocalcinosis with a -4-basepair G-to-A transition in the 5\u2032-untranslated region of ANKH that promotes enhanced expression of ANKH protein and excess generation of extracellular pyrophosphate","volume":"52","author":"Zhang","year":"2005","journal-title":"Arthritis Rheum"}],"container-title":["Rheumatic Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X06000263?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X06000263?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:04:40Z","timestamp":1760180680000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889857X06000263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5]]},"references-count":155,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["S0889857X06000263"],"URL":"https:\/\/doi.org\/10.1016\/j.rdc.2006.03.003","relation":{},"ISSN":["0889-857X"],"issn-type":[{"type":"print","value":"0889-857X"}],"subject":[],"published":{"date-parts":[[2006,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of Crystal Arthropathy\u2014History and Advances","name":"articletitle","label":"Article Title"},{"value":"Rheumatic Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rdc.2006.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}